openPR Logo
Press release

Europe Malaria Treatment Market to exceed US$ 451.69 million by 2030, says Business Market Insights

03-05-2025 08:11 AM CET | Health & Medicine

Press release from: Business Market Insights

Europe Malaria Treatment Market to exceed US$ 451.69 million

The Europe malaria treatment market was valued at US$ 451.69 million in 2022 and is expected to reach US$ 3,060.97 million by 2030; it is estimated to grow at a CAGR of 27.0% from 2022 to 2030. Analysis - by Treatment (Generic Drugs, Originators, Vaccines, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

Get PDF Sample Report + All Related Table and Graphs @: https://www.businessmarketinsights.com/sample/TIPRE00025038?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: Europe Malaria Treatment Market:

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

A few antimalarial that are under clinical development are mentioned in the table below:Malaria Drugs/Vaccine/Compounds Under Clinical Development

Cipla Ltd
Sun Pharmaceutical Industries Ltd
Sanofi SA
GSK Plc
Novartis AG
Pfizer Inc
Lupin Ltd
Bottom of Form

Chapter Details of Europe Malaria Treatment Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Europe Malaria Treatment Market Landscape
Part 04: Europe Malaria Treatment Market Sizing
Part 05: Europe Malaria Treatment Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.businessmarketinsights.com/buy/TIPRE00025038?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sonam Patil
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Bussiness Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe Malaria Treatment Market to exceed US$ 451.69 million by 2030, says Business Market Insights here

News-ID: 3898235 • Views:

More Releases from Business Market Insights

North America Demineralized Whey Powder Market Research Report
The North America demineralized whey powder market was valued at US$ 172.56 million in 2023 and is expected to reach US$ 241.68 million by 2031; it is estimated to record a CAGR of 4.3% from 2023 to 2031. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Demineralized Whey Powder Market 2031. in addition, the report within the market
North America Defibrillator Market Overview by Top Manufacturers 2028
The defibrillator market in North America is expected to grow from US$ 4,575.28 million in 2021 to US$ 6,597.93 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Defibrillator Market 2028. in addition, the report within the market overview section outlines PLC
North America Defense Integrated Antenna Market Recent Trends by Forecast to 202 …
North America defense integrated antenna market is expected to grow from US$ 461.89 million in 2022 to US$ 707.29 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2022 to 2028. The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the North America Defense Integrated Antenna Market 2028. in addition, the report within the market overview section
Cancer Chemotherapy Market Analysis, Share, Trend, Industry Report Forecast till 2031
Cancer Chemotherapy Market Analysis, Share, Trend, Industry Report Forecast till …
The cancer chemotherapy market size is expected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024. The market is estimated to record a CAGR of 11.5% from 2025 to 2031. Europe Commercial Refrigeration Market Overview Executive Summary and Global Market Analysis: The global cancer chemotherapy market is experiencing significant growth driven by rising global incidence of cancer coupled with an aging population, increasing access to oncology care in

All 5 Releases


More Releases for Malaria

Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database. Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
03-08-2017 | Health & Medicine
TMR
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in